Insulin-like Growth Factor-1 Receptor Inhibitors

Abstract

The present invention relates to compounds that are capable of inhibiting, modulating and/or regulating Insulin-Like Growth Factor I Receptor and Insulin Receptor. The compounds of the instant invention possess a core structure that comprises a sulfonyl indole moiety. The present invention is also related to the pharmaceutically acceptable salts, hydrates and stereoisomers of these compounds.

Publication
Patent: WO 2013/148227
Chandrika B-Rao
Chandrika B-Rao
Independent Consultant

Drug Discovery, Bioinformatics and Statistics